Horizon Discovery Group plc: Trading Update Trading Update FY2016 revenue in line with guidance as Group drives to positive EBITDA Group on track to meet market expectations in FY2017 Cambridge, UK, 24 January 2017: Horizon...

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research Access to CRISPR for the generation of GMP biomanufacturing cell lines...

Horizon Discovery Group plc: Interim Results for the Six Months Ended 30 June 2016 HORIZON DISCOVERY GROUP PLC ("Horizon", "the Group" or "the Company") Interim Results for the Six Months Ended 30 June 2016 Strong Revenue Growth and Focus on Operational Gearing Underpin Path...

Horizon Discovery Group and Ventana Medical Systems Sign Co-development Agreement for Reference Standards On a project by project basis, Horizon to co-develop and commercialise IHC Reference Standards with Ventana Medical Systems, Inc. (a member of the Roche Group and innovator of tissue-based...